The role of IGFBP7, mimecan and osteopontin in the management of heart failure with preserved and reduced ejection fraction.
29 April 2017 (08:30 - 17:30)
Organised by:
Abstract
About the speaker
Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))
76 More presentations in this session
Access the full session
The Event
Heart Failure 2017 - 4th World Congress on Acute Heart Failure
29 April 2017
08:30 CET
